Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure

References

• Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Palatini P, Parati G, European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302.
   PubMed Web of Science ®Google Scholar
• Omboni S, Aristizabal D, De la Sierra A, et al. ARTEMIS (International Ambulatory Blood Pressure Registry: TEleMonitoring of hypertension and cardiovascular rISk project) investigators. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34(11):2187–2198.
   PubMed Web of Science ®Google Scholar
• Alwan H, Pruijm M, Ponte B, et al. Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study. PLoS One. 2014;9(3):e92522.
   PubMed Web of Science ®Google Scholar
• Conen D, Aeschbacher S, Thijs L, et al. Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension. 2014;64(5):1073–1079.
   PubMed Web of Science ®Google Scholar
• Lin YT, Lampa E, Fall T, et al. Blood pressure phenotypes based on ambulatory monitoring in a general middle-aged population. Blood Press. 2021;30(4):237–249.
   PubMed Web of Science ®Google Scholar
• Eguchi K, Ishikawa J, Hoshide S, et al. Masked hypertension in diabetes mellitus: a potential risk. J Clin Hypertension. 2007;9(8):601–607.
   Google Scholar
• Marchesi C, Maresca AM, Solbiati F, et al. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function. Am J Hypertens. 2007;20(10):1079–1084.
   PubMed Web of Science ®Google Scholar
• Gupta H, Vidhale T, Pustake M, et al. Utility of ambulatory blood pressure monitoring in detection of masked hypertension and risk of hypertension mediated organ damage in normotensive patients with type 2 diabetes mellitus. Blood Press. 2022;31(1):50–57.
   PubMed Web of Science ®Google Scholar
• Esteche VT, Sposito P, Acosta C, et al. Association between smoking and hypertension control: descriptive and analytical study. Eur Respirat J. 2021;58:PA2443.
   Google Scholar
• Kawano Y. Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertens Res. 2010;33(3):181–191.
   PubMed Web of Science ®Google Scholar
• Mori TA, Burke V, Zilkens RR, et al. The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention. J Hypertens. 2016;34(3):421–428.
   PubMed Web of Science ®Google Scholar
• Kotsis V, Stabouli S, Bouldin M, et al. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 2005;45(4):602–607.
   PubMed Web of Science ®Google Scholar
• Bromfield SG, Shimbo D, Booth JN, 3rd, et al. Cardiovascular risk factors and masked hypertension: the Jackson Heart Study. Hypertension. 2016;68(6):1475–1482.
   PubMed Web of Science ®Google Scholar
• Holanger M, Kjeldsen SE, Jamerson K, HOT Study investigators, et al. HOT study investigators. Smoking and overweight associated with masked uncontrolled hypertension: a hypertension optimal treatment (HOT) Sub-Study. Blood Press. 2021;30(1):51–59.
   PubMed Web of Science ®Google Scholar
• Abdalla M, Booth JN, 3rd, Seals SR, et al. Masked hypertension and incident clinic hypertension Among blacks in the Jackson Heart Study. Hypertension. 2016;68(1):220–226.
   PubMed Web of Science ®Google Scholar
• Shimbo D, Newman JD, Schwartz JE. Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the masked hypertension study. Am J Hypertens. 2012;25(6):664–671.
   PubMed Web of Science ®Google Scholar
• Zhang DY, Cheng YB, Guo QH, et al. Subtypes of masked hypertension and target organ damage in untreated outpatients. Blood Press. 2020;29(5):299–307.
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47(5):846–853.
   PubMed Web of Science ®Google Scholar
• Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342–1349.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a Meta-analysis. J Hypertens. 2007;25(11):2193–2198.
   PubMed Web of Science ®Google Scholar
• Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347(11):797–805.
   PubMed Web of Science ®Google Scholar
• Parati G, Agabiti-Rosei E, Bakris GL, et al. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) study: a randomised controlled trial protocol. BMJ Open. 2018;8(12):e021038.
   PubMed Web of Science ®Google Scholar
• Parati G, Bilo G. Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care. 2009;32(suppl_2):S298–S304.
   PubMedGoogle Scholar
• Franklin SS, O'Brien E, Staessen JA. Masked hypertension: understanding its complexity. Eur Heart J. 2017;38(15):1112–1118.
   PubMed Web of Science ®Google Scholar
• Parati G, Stergiou GS, Bilo G, et al. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the working group on blood pressure monitoring and cardiovascular variability of the European Society of Hypertension. J Hypertens. 2021;39(9):1742–1767.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Mukkamala R, Avolio A, et al. Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension working group on blood pressure monitoring and cardiovascular variability. J Hypertens. 2022;40(7):1380–1387.
   PubMedGoogle Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022;40(1):10–38.
   PubMedGoogle Scholar
• American Diabetes Association Professional Practice Committee. Addendum 10. Cardiovascular disease and risk management: Standards of medical care in diabetes—2022. Diabetes Care. 2022;45(Suppl. 1):S144–S174.
   PubMedGoogle Scholar
• Cosentino F, Grant PJ, Aboyans V, ESC Scientific Document Group, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41(2):255–323.
   PubMed Web of Science ®Google Scholar